文献速递临床试验与 GCP流行病学与生物统计

白癜风国际工作组达成核心数据清单共识(VITAL):白癜风核心结局集(COS)及临床试验、登记和临床实践中背景因素的研究方案

Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
PubMed 文献 · Trials · 2022-07-23

白癜风领域缺乏标准化数据收集共识,导致数据难以准确解读、比较和合并。VITAL项目旨在为临床试验、登记和临床实践制定核心结局集(COS),包括核心域集和核心测量工具集,并补充背景因素。项目分两部分:第一部分通过电子调查(e-Delphi技术)和共识会议确定各场景的核心域集(测什么)及背景因素;第二部分基于共识会议选择核心测量工具(怎么测)及测量细节,并参照C3、HOME、COSMIN和OMERACT推荐。最终将统一临床试验、登记和临床实践的数据收集,促进白癜风新见解。

要点

  • VITAL项目旨在为白癜风临床试验、登记和临床实践制定核心结局集(COS)及背景因素。
  • 第一部分通过e-Delphi调查和共识会议确定各场景的核心域集(测什么)及背景因素。
  • 第二部分基于共识会议选择核心测量工具(怎么测)及测量细节,参照C3、HOME、COSMIN和OMERACT推荐。

核心结论

  • 本项目将统一临床试验、登记和临床实践之间的数据收集,促进白癜风新见解。

研究设计与样本

  • 研究方案:分两部分,第一部分基于电子调查(e-Delphi技术)和大型国际利益相关者共识会议选择各场景的核心域集及背景因素;第二部分基于共识会议选择核心测量工具及测量细节,参照C3、HOME、COSMIN和OMERACT推荐。
  • 2015年已达成的首个白癜风临床试验核心域集将在准备阶段重新评估,并作为启动共识过程的结局域列表基础。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a lack of consensus related to the collection of standardized data for individuals with vitiligo enrolled in clinical trials and registries as well as those seen in clinical practice which causes difficulty in accurately interpreting, comparing, and pooling of data. Several years ago, efforts to initiate work on developing core outcome sets were performed and a consensus was reached in 2015 on the first core domain set for vitiligo clinical trials. METHODS/DESIGN: This project aims to further develop a core outcome set for vitiligo clinical trials as well as create internationally agreed-upon core outcome sets for registries and clinical practice. These core outcome sets will include a core domain set and a core measurement instruments set and will be supplemented by contextual factors, including baseline and treatment-related characteristics. In a preparatory exercise, the 2015 core domain set will be re-evaluated and will serve as the basis for the list of outcome domains used to initiate the consensus process. This project will consist of two parts. Part 1 will focus on the selection of a core domain set, or "what to measure" and contextual factors, for each setting based on electronic surveys (e-Delphi technique) and a conclusive consensus meeting by a large group of international stakeholders. Part 2 will include selection of core measurement instruments, or "how to measure," and measurement details (e.g., scale and timing) for the core domain sets and contextual factors agreed upon in part 1. Part 2 will be based on consensus meetings with stakeholders involved in part 1 and will be guided by C3 (CHORD-COUSIN Collaboration), Harmonising Outcome Measures for Eczema (HOME), COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN), and Outcome Measures in Rheumatology (OMERACT) recommendations including information on measurement properties of available instruments (systematic review and expert/patient opinion). At the end of part 2, all stakeholders involved will be invited to participate in a final meeting in which the ultimate core data sets (core outcome sets and contextual factors) will be presented and the dissemination plan and implementation goals will be defined. DISCUSSION: This project will harmonize data collection between clinical trials, registries, and clinical practices, facilitating new insights in vitiligo. TRIAL REGISTRATION: This study is registered in the Core Outcome Measures for Effectiveness Trials (COMET) database and on the C3 (CHORD-COUSIN Collaboration) website.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van Geel N, Hamzavi IH, Pandya AG, et al. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice. Trials. 2022. PMID: 35871019. doi:10.1186/s13063-022-06497-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。